A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Interventions
DRUG

Bardoxolone Methyl

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY